Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing–remitting multiple sclerosis: a case–control study - Scorecard - MDSpire
Advertisement
Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing–remitting multiple sclerosis: a case–control study
Clinical Scorecard: Variations in Immune-Associated Semaphorin Concentrations in Cerebrospinal Fluid and Serum of Newly Diagnosed, Untreated Patients with Relapsing-Remitting Multiple Sclerosis: A Case-Control Analysis
At a Glance
Category
Detail
Condition
Relapsing-Remitting Multiple Sclerosis
Key Mechanisms
Semaphorins regulate immune and nervous systems, influencing inflammation and neurodegeneration.
Target Population
Newly diagnosed, treatment-naive patients with RRMS.
Care Setting
Neurology department in a clinical research setting.
Key Highlights
Lower serum levels of Sema3A, Sema4A, and Sema7A in RRMS patients compared to healthy controls.
Negative correlation between OCB count and serum Sema4A and Sema7A.
Higher CSF Sema4A levels in patients with infratentorial lesions.
Sema4D levels were elevated in patients with an IgG index ≥0.7.
Low serum Sema3A levels may have diagnostic relevance in RRMS.
Guideline-Based Recommendations
Diagnosis
Evaluate semaphorin levels as potential biomarkers in RRMS.
Management
Consider the role of semaphorins in therapeutic targeting for MS.
Monitoring & Follow-up
Monitor semaphorin levels in relation to disease progression and treatment response.
Risks
Be aware of the implications of altered semaphorin levels in immune activation and neuroinflammation.
Patient & Prescribing Data
Patients aged 18–65 years with definite diagnosis of RRMS.
Further studies needed to establish the therapeutic relevance of semaphorins.
Clinical Best Practices
Utilize semaphorin levels in conjunction with clinical assessments for comprehensive patient evaluation.
Incorporate OCB count in the assessment of immune activity in RRMS.
